Sees FY25 non-GAAP gross margin of 76%-78%, FY25 non-GAAP R&D expense of $90M-$105M, and FY25 non-GAAP SG&A expense of $290M-$320M.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PCRX: